HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients

Abstract Background Even after 3 years from SARS-CoV-2 identification, COVID-19 is still a persistent and dangerous global infectious disease. Significant improvements in our understanding of the disease pathophysiology have now been achieved. Nonetheless, reliable and accurate biomarkers for the ea...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Simona Greco, Alisia Made’, Martina Mutoli, Lu Zhang, Santiago Nicolas Piella, Mélanie Vausort, Andrew I. Lumley, Antonio Paolo Beltrami, Prashant Kumar Srivastava, Valentina Milani, Sara Boveri, Marco Ranucci, Laura Valentina Renna, Hüseyin Firat, Antonino Bruno, Gaia Spinetti, Costanza Emanueli, Yvan Devaux, Fabio Martelli
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-10-01
Saila:	Journal of Translational Medicine
Sarrera elektronikoa:	https://doi.org/10.1186/s12967-023-04497-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!